Comparison between Opto Circuits (India) FPO and Plethico Pharmaceuticals IPO.
Opto Circuits (India) FPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Plethico Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Opto Circuits (India) FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Logo | ||
| Issue Category | Mainboard | Mainboard |
| Issue Type | FPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | ||
| Registrar | ||
| Market Maker | ||
| DRHP | ||
| RHP | ||
| Final Prospectus | Final Prospectus ![]() | Final Prospectus ![]() |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Opto Circuits (India) FPO is up to ₹108.00 Cr whereas the issue size of the Plethico Pharmaceuticals IPO is up to ₹110.00 Cr. The final issue price of Opto Circuits (India) FPO is ₹270.00 per share and of Plethico Pharmaceuticals IPO is ₹300.00 per share.
| Opto Circuits (India) FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹240.00 per share | ₹280.00 per share |
| Issue Price (Upper) | ₹270.00 per share | ₹300.00 per share |
| Issue Price (Final) | ₹270.00 per share | ₹300.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 40,00,000 shares | 36,66,667 shares |
| Fresh Issue Size (Amount) | up to ₹108.00 Cr | up to ₹110.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 40,00,000 shares | 36,66,667 shares |
| Issue Size Total (Amount) | up to ₹108.00 Cr | up to ₹110.00 Cr |
Opto Circuits (India) FPO opens on Mar 31, 2006, while Plethico Pharmaceuticals IPO opens on Apr 10, 2006. The closing date of Opto Circuits (India) FPO and Plethico Pharmaceuticals IPO is Apr 05, 2006, and Apr 17, 2006, respectively.
Opto Circuits (India) FPO P/E ratio is , as compared to Plethico Pharmaceuticals IPO P/E ratio of .
| Opto Circuits (India) FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 35.59 | 97.5 |
| Promoter Shareholding (Post-Issue) | 30.98 | 87.01 |
| P/E Ratio | ||
| Market Cap | ₹831.82 Cr. | ₹1022.00 Cr. |
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Opto Circuits (India) FPO Retail Individual Investors (RII) are offered 11,20,000 shares while in Plethico Pharmaceuticals IPO retail investors are offered 11,20,000 shares. Qualified Institutional Buyers (QIB) are offered 16,00,000 shares in Opto Circuits (India) FPO and 22,00,000 shares in Plethico Pharmaceuticals IPO.
| Opto Circuits (India) FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 16,00,000 shares | 22,00,000 shares |
| NII | 4,80,000 shares | 3,66,667 shares |
| RII | 11,20,000 shares | 11,00,000 shares |
| Employee | 4,00,000 shares | 0 shares |
| Others | ||
| Total | 40,00,000 shares | 36,66,667 shares |
Opto Circuits (India) FPO subscribed in total, whereas Plethico Pharmaceuticals IPO subscribed .